Navigation Links
Risk of colorectal cancer extremely low 5 years after a normal colonoscopy screening
Date:9/22/2008

OAK BROOK, Ill. September 22, 2008 A study appearing in the Sept. 18 issue of the New England Journal of Medicine shows that among individuals with no colorectal neoplasia (abnormal growths) on initial screening colonoscopy, the five-year risk of colorectal cancer is extremely low. The data provides support for rescreening at an interval of five years or longer after a normal colonoscopic examination.

"This research is very significant as it is the first large study to provide direct rescreening data on a group of average risk patients who had normal findings on the initial screening colonoscopy," said John L. Petrini, MD, FASGE, president, American Society for Gastrointestinal Endoscopy (ASGE). "As a result, physicians should consider this important finding when recommending a rescreening schedule to their patients, as this data could have an impact on the costs of colonoscopy and the resources to provide for colonoscopy. There is data suggesting that the procedure may be performed too frequently."

Researchers, led by Thomas F. Imperiale, MD, of the Indiana University School of Medicine and the Regenstrief Institute, examined 1,256 asymptomatic patients 50 years or older, who had no precancerous or cancerous findings on baseline colonoscopy and who underwent follow up colonoscopy at five years. Among this patient population, no cancers were discovered. Advanced adenomas were found in 16 patients (1.3 percent).

ASGE and American Cancer Society colorectal cancer screening guidelines for patients with normal findings on the initial screening colonoscopy recommend repeat screening for average risk individuals every 10 years if they have no symptoms or family history risk. While this data does not directly evaluate the 10-year recommendation, it does establish that colonoscopy screening does not need to be repeated before five years for average risk individuals.

An estimated 49,960 deaths are expected to occur from colorectal cancer in 2008. According to a study released in October 2007 from the CDC and the American Cancer Society, colorectal cancer deaths dropped nearly 5 percent between 2002 and 2004, more than the other major cancer killers (prostate, breast, and lung). Among the key factors playing a role in the decline was prevention through screening and the removal of precancerous polyps.

"This is excellent news and reinforces the importance of colorectal cancer screening beginning at age 50, or even younger if there is a family history of colorectal cancer or polyps," said Petrini. "Colonoscopy plays a very important role in colorectal cancer screening and prevention because it is the only method that allows us to remove polyps before they turn into cancer."


'/>"/>

Contact: Anne Brownsey
abrownsey@asge.org
630-570-5635
American Society for Gastrointestinal Endoscopy
Source:Eurekalert

Related medicine news :

1. UC Davis doctors use multimedia to increase colorectal cancer screening among Hispanics
2. Many colorectal cancer survivors do not receive recommended follow-up care
3. National Coalition for Quality Colorectal Cancer Screening and Care Appoints New Executive Director, Randall H. H. Madry:
4. Study confirms colorectal cancer screening should start at age 50
5. PET scans lead to treatment changes in majority of colorectal cancer patients
6. Turned-off cannabinoid receptor turns on colorectal tumor growth
7. FDA Grants AMDL Clearance to Market the AMDL-ELISA DR-70(R) (FDP) Blood Test for Monitoring Colorectal Cancer
8. DiagnoCures GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group
9. MIT researchers see alternative to common colorectal cancer drug
10. Family history and screening for colorectal cancer
11. Family history of colorectal cancer linked with reduced risk of cancer recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 2017 ResMed (NYSE: RMD ), BMC ( ... Haven, Florida ) today announced they have agreed on a ... will be permitted to sell their existing products in exchange for ... payment to 3B to close the Florida ... admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
Breaking Medicine Technology: